{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:08:41Z","timestamp":1782767321458,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113875","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T03:51:30Z","timestamp":1734753090000},"page":"113875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["High-titer rheumatologic markers in serum of veterans with severe pulmonary complications 25\u201330\u00a0years after sulfur mustard exposure"],"prefix":"10.1016","volume":"146","author":[{"given":"Shamsa","family":"Shariatpanahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Soroush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar","family":"Poorfarzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Faghihzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Yaraee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-7095","authenticated-orcid":false,"given":"Tooba","family":"Ghazanfari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113875_b0005","first-page":"300","article-title":"Vesicant agents","volume":"177","author":"Prentiss","year":"1937","journal-title":"Chemicals in Warfare: A Treatise on Chemical Warfare."},{"key":"10.1016\/j.intimp.2024.113875_b0010","first-page":"228","article-title":"Vesicants","volume":"197","author":"Sidell","year":"1997","journal-title":"Medical Aspects of Chemical and Biological Warfare."},{"issue":"7","key":"10.1016\/j.intimp.2024.113875_b0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jat.1581","article-title":"Mustard gas toxicity: the acute and chronic pathological effects","volume":"30","author":"Ghabili","year":"2010","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113875_b0020","first-page":"289","article-title":"Toxicology and pharmacology of the chemical warfare agent sulfur mustard","volume":"48","author":"Dacre","year":"1996","journal-title":"Pharmacol. Rev."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2024.113875_b0025","first-page":"471","article-title":"Appendix E: health risk assessment for sulfur mustard (HD)","volume":"59","author":"Bakshi","year":"2000","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.intimp.2024.113875_b0030","unstructured":"Balali-Mood M, editor First report of delayed toxic effects of Yperite poisoning in Iranian fighters1986."},{"issue":"6","key":"10.1016\/j.intimp.2024.113875_b0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1472-8206.2005.00364.x","article-title":"Long\u2010term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans","volume":"19","author":"Balali-Mood","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113875_b0040","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/01.jom.0000094993.20914.d1","article-title":"Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent","author":"Khateri","year":"2003","journal-title":"J. Occup. Environ. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0045","first-page":"75","article-title":"Studying the surrogate validity of respiratory indexes in predicting the respiratory illnesses in wounded people exposed to sulfur mustard","volume":"13","author":"Kavehie","year":"2011","journal-title":"J. Arak Univ. Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1742-7843.2006.pto_429.x","article-title":"Comparison of early and late toxic effects of sulfur mustard in Iranian veterans","volume":"99","author":"Balali-Mood","year":"2006","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2024.113875_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2018.05.008","article-title":"DNA damage and telomere length shortening in the peripheral blood leukocytes of 20 years SM-exposed veterans","volume":"61","author":"Behboudi","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.intimp.2024.113875_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415803","article-title":"Implications of post-translational modifications in autoimmunity with emphasis on citrullination, homocitrullination and acetylation for the pathogenesis, diagnosis and prognosis of rheumatoid arthritis","volume":"23","author":"Haro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7\u20139","key":"10.1016\/j.intimp.2024.113875_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/ars.2021.0064","article-title":"Redox-mediated carbamylation as a hapten model applied to the origin of antibodies to modified proteins in rheumatoid arthritis","volume":"36","author":"Trejo-Zambrano","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"13\u201314","key":"10.1016\/j.intimp.2024.113875_b0070","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.intimp.2009.08.021","article-title":"Evaluation of relationship between the serum levels of inflammatory mediators and ocular injuries induced by sulfur mustard: Sardasht-Iran Cohort Study","volume":"9","author":"Ghasemi","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113875_b0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15569540802689451","article-title":"Long-term rheumatologic complications of sulfur mustard in victims of Sardasht","volume":"28","author":"Shariat-Panahi","year":"2009","journal-title":"Iran. Toxin Reviews."},{"issue":"13\u201314","key":"10.1016\/j.intimp.2024.113875_b0080","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.intimp.2009.09.002","article-title":"Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: sardasht-iran cohort study","volume":"9","author":"Pourfarzam","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5114\/reum.2018.77976","article-title":"Antinuclear antibodies in healthy people and non-rheumatic diseases\u2013diagnostic and clinical implications","volume":"56","author":"Grygiel-G\u00f3rniak","year":"2018","journal-title":"Reumatologia\/Rheumatology."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5114\/reum.2018.77976","article-title":"Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications","volume":"56","author":"Grygiel-G\u00f3rniak","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.intimp.2024.113875_b0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exger.2015.12.009","article-title":"Aging-dependent decline of IL-10 producing B cells coincides with production of antinuclear antibodies but not rheumatoid factors","volume":"75","author":"van der Geest","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.intimp.2024.113875_b0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-4943(02)00106-1","article-title":"Prevalence of non organ-specific autoantibodies in healthy centenarians","volume":"8","author":"Candore","year":"2002","journal-title":"Arch. Gerontol. Geriatr. Suppl."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2006.10.002","article-title":"Antinuclear antibodies in the oldest-old women and men","volume":"27","author":"Nilsson","year":"2006","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.intimp.2024.113875_b0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113875_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20096","article-title":"Anti-DFS70 antibodies in 597 healthy hospital workers","volume":"50","author":"Watanabe","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2024.113875_b0120","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jaci.2006.11.360","article-title":"Systemic Autoimmunity significance in patients with asthma","volume":"119","author":"Agache","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113875_b0125","unstructured":"Agache I, Duca L, Anghel M, Pamfil GH. Antinuclear antibodies in asthma patients-a special asthma phenotype? 2009."},{"issue":"6","key":"10.1016\/j.intimp.2024.113875_b0130","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1164\/ajrccm.152.6.8520733","article-title":"Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance","volume":"152","author":"Szczeklik","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113875_b0135","first-page":"52","article-title":"Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections","volume":"77","author":"Coffey","year":"1989","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0140","first-page":"671","article-title":"IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease","volume":"35","author":"Sakaida","year":"1995","journal-title":"Ryumachi[Rheumatism]."},{"issue":"1","key":"10.1016\/j.intimp.2024.113875_b0145","doi-asserted-by":"crossref","first-page":"22821","DOI":"10.1038\/s41598-021-02066-9","article-title":"High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease","volume":"11","author":"Tyker","year":"2021","journal-title":"Sci. Rep."},{"issue":"160","key":"10.1016\/j.intimp.2024.113875_b0150","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur. Respir. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2024.113875_b0155","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis & Rheumatology."},{"key":"10.1016\/j.intimp.2024.113875_b0160","doi-asserted-by":"crossref","unstructured":"Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Van Raemdonck DE, Dupont LJ, Verleden GM, editors. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?2009: Elsevier.","DOI":"10.1016\/j.transproceed.2008.12.024"},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0165","first-page":"414","article-title":"C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure","volume":"5","author":"Aksu","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.113875_b0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1183\/09031936.00088209","article-title":"Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study","volume":"35","author":"Eagan","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.intimp.2024.113875_b0175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/thx.2004.035774","article-title":"C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study","volume":"60","author":"\u00d3lafsd\u00f3ttir","year":"2005","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.intimp.2024.113875_b0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000076671","article-title":"Chlamydia pneumoniae infection and inflammation in adults with asthma","volume":"71","author":"S\u00e4vykoski","year":"2004","journal-title":"Respiration"},{"issue":"7","key":"10.1016\/j.intimp.2024.113875_b0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1081\/JAS-120023497","article-title":"Asthma, body mass index, and C-reactive protein among US adults","volume":"40","author":"Ford","year":"2003","journal-title":"J. Asthma"},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1081-1206(10)62039-X","article-title":"The association of sensitive systemic inflammation markers with bronchial asthma","volume":"89","author":"Jousilahti","year":"2002","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113875_b0195","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.intimp.2024.113875_b0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0002-9343(03)00185-2","article-title":"Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination","volume":"114","author":"Mannino","year":"2003","journal-title":"Am. J. Med."},{"issue":"14","key":"10.1016\/j.intimp.2024.113875_b0205","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.113875_b0210","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/aje\/155.9.842","article-title":"Lipids and pulmonary function in the third national health and nutrition examination survey","volume":"155","author":"Cirillo","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113875_b0215","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/thx.2003.015768","article-title":"Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study","volume":"59","author":"Kony","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.intimp.2024.113875_b0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/01480540701688840","article-title":"Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses","volume":"31","author":"Ray","year":"2008","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.intimp.2024.113875_b0225","unstructured":"Feister AJ. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. 1991."},{"key":"10.1016\/j.intimp.2024.113875_b0230","article-title":"Flow cytometric analysis of toxicity by vesicating agents in human cells in vitro.(Reannouncement with new availability information)","author":"Smith","year":"1991","journal-title":"Army Medical Res. Inst. of Chem. Defense, Aberdeen Proving Ground, MD\u2026;"},{"key":"10.1016\/j.intimp.2024.113875_b0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02443803","article-title":"The use of human epidermal keratinocytes in culture as a model for studying the biochemical mechanisms of sulfur mustard toxicity","volume":"6","author":"Smith","year":"1990","journal-title":"Cell Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113875_b0240","first-page":"193","article-title":"Ultrastructural correlates of sulfur mustard toxicity","volume":"9","author":"Petrali","year":"1990","journal-title":"J. Toxicol: Cutaneous and Ocul. Toxicol."},{"key":"10.1016\/j.intimp.2024.113875_b0245","first-page":"233","article-title":"The use of human leukocytes as a model for studying the biochemical effects of chemical warfare (CW) agents","author":"Meier","year":"1984","journal-title":"Defense Biosci. Rev."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.113875_b0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.toxlet.2009.09.008","article-title":"Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures","volume":"191","author":"Heinrich","year":"2009","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2024.113875_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.toxlet.2015.04.006","article-title":"Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK\/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators","volume":"235","author":"Kumar","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.113875_b0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2478\/intox-2013-0029","article-title":"Sulfur mustard induced oxidative stress and its alteration using asoxime (HI-6)","volume":"6","author":"Pohanka","year":"2013","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.intimp.2024.113875_b0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrgentox.2016.03.006","article-title":"Gene expression profile of oxidative stress and antioxidant defense in lung tissue of patients exposed to sulfur mustard","volume":"800","author":"Tahmasbpour","year":"2016","journal-title":"Mutat. Res\/Genet. Toxicol. Environ. Mutagen."},{"issue":"12","key":"10.1016\/j.intimp.2024.113875_b0270","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0960327109354311","article-title":"Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases","volume":"28","author":"Attaran","year":"2009","journal-title":"Hum. Exp. Toxicol."},{"issue":"13\u201314","key":"10.1016\/j.intimp.2024.113875_b0275","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.intimp.2009.08.019","article-title":"Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: sardasht-iran cohort study","volume":"9","author":"Ghazanfari","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113875_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar63","article-title":"Death, autoantigen modifications, and tolerance","volume":"2","author":"Utz","year":"2000","journal-title":"Arthritis Res. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692402397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692402397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:53:37Z","timestamp":1736614417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692402397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"alternative-id":["S156757692402397X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113875","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-titer rheumatologic markers in serum of veterans with severe pulmonary complications 25\u201330\u00a0years after sulfur mustard exposure","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113875"}}